The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
555 jobs Number of planned job losses
Announcement Date
27 December 2006
Employment effect (start)
1 January 2007
Foreseen end date
31 December 2007
Description
The pharmaceutical company Eli Lilly has confirmed it will close its Hampshire manufacturing plant.
In June, Eli Lilly said it planned to close the factory unless an alternative drugs firm could take over the Basingstoke site and its 555 employees.
No buyer was found and manufacturing will stop at the end of 2007.
Company directors have said the cuts have been made due to "over capacity" and they hope to relocate some employees to other UK sites.
The company had carried out employee consultation on the closure and has said about 100 employees will be eligible for retirement.
US-based Eli Lilly manufactures medicines including Prozac, a treatment for clinical depression and Cialis, a treatment for erectile dysfunction.
Sources
27 December 2006: BBC Website
Citation
Eurofound (2006), Eli Lilly, Closure in United Kingdom, factsheet number 64678, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/64678.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
